EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION

Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study

(2016) Richard Weisler et al.   CNS SPECTRUMS

Effects of anxiety on the long-term course of depressive disorders

(2011) William Coryell et al.   BRITISH JOURNAL OF PSYCHIATRY

Severe and anxious depression: Combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors

(2011) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder

(2011) Charles Merideth et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder

(2011) Arifulla Khan et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆

(2010) Brian Bortnick et al.   JOURNAL OF AFFECTIVE DISORDERS

Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis

(2009) J. Craig Nelson et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

(2009) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Adjunctive Aripiprazole in Major Depressive Disorder

(2009) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)

(2009) George I. Papakostas et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

(2009) Andrew J. Cutler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report

(2008) Maurizio Fava et al.   AMERICAN JOURNAL OF PSYCHIATRY

Anxious versus non-anxious depression: difference in treatment outcome

(2008) K. Domschke et al.   JOURNAL OF PSYCHOPHARMACOLOGY